Breaking News
December 11, 2018 - Cartilage tissue engineering brings good news for patients with cartilage defects
December 11, 2018 - Novel 3D printing workflow helps predict leaky heart valves
December 11, 2018 - Are caries linked to political regime?
December 11, 2018 - Leader in Diabetes Clinical Trials Wins Naomi Berrie Award
December 11, 2018 - Scientists discover cellular mechanism that triggers pneumonia in humans
December 11, 2018 - Increasing mental health problems related to drug use in over 55’s
December 11, 2018 - High-intensity interval exercise could help combat cognitive dysfunction in obese people
December 11, 2018 - Annual flu shot can save lives of heart failure patients
December 11, 2018 - Researchers compare health outcomes for VA and non-VA hospitals
December 11, 2018 - Recommendations Developed for Psoriatic Arthritis Treatment
December 11, 2018 - Genetic analysis links obesity with diabetes, coronary artery disease
December 11, 2018 - Study shows that having genetic information can affect how the body responds
December 11, 2018 - UNAIDS Report: 9 Million Are Likely HIV Positive And Don't Know It
December 11, 2018 - Lund University researchers succeed in obtaining dendritic cells by direct reprogramming
December 11, 2018 - Breast tumors recruit bone marrow cells to boost their growth, study reveals
December 11, 2018 - Updated breast cancer screening guideline highlights importance of shared decision-making
December 11, 2018 - EHR-related stress associated with physician burnout
December 11, 2018 - AHA: 12-Year-Old Heart Defect Survivor Inspires NFL Player’s Foundation
December 11, 2018 - Breast cancer patients who take heart drug with trastuzumab have less heart damage
December 11, 2018 - Providing aid to those humans – and animals – affected by the California fires
December 11, 2018 - Even without proof, CBD is finding a niche as a cure-all
December 11, 2018 - Drawing leads to better memory than writing
December 11, 2018 - Researchers report novel findings on plant hormone
December 10, 2018 - A Tale of Two Labels
December 10, 2018 - Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
December 10, 2018 - A 14-year-old explains what it’s like to get a new heart
December 10, 2018 - Team Players Honored with 2018 Baton Awards
December 10, 2018 - Global report highlights how the changing world is affecting children’s physical activity levels
December 10, 2018 - Genes play a role in physical activity and sleep
December 10, 2018 - DDT in Alaskan fish shown to increase risk of cancer
December 10, 2018 - Laws to curb use of cell phones have greatly reduced fatalities for motorcyclists
December 10, 2018 - Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia
December 10, 2018 - University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
December 10, 2018 - The heartbeat seat: Demoing new well-being technologies in a car
December 10, 2018 - Leading Cancer Researcher to Direct Herbert Irving Comprehensive Cancer Center
December 10, 2018 - Researchers explore how glial cells develop in the brain from neural precursor cells
December 10, 2018 - Study compares pain-related diagnoses in First Nations and non-First Nations children, youth
December 10, 2018 - Experts address sleep disorders following traumatic brain injury
December 10, 2018 - Scientists find answers to how cancer spreads
December 10, 2018 - Study explores why older people read more slowly
December 10, 2018 - Smart life-collar could save lives of young children
December 10, 2018 - Asbestos found in most NHS hospitals finds BBC inquiry
December 10, 2018 - Researchers use new technique to probe hydrogen bonds
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Episodic memory tests help in predicting brain atrophy and Alzheimer’s disease
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
Nasal delivery of weight-loss hormone eases breathing problems in sleeping mice

Nasal delivery of weight-loss hormone eases breathing problems in sleeping mice

image_pdfDownload PDFimage_print

Experimenting with mice, Johns Hopkins Medicine researchers have added to evidence that a hormone best known for helping regulate hunger and body weight might also ease breathing problems experienced during sleep more effectively when given through the nose.

Although clinical trials using the hormone, known as leptin, aren’t yet on the horizon, the investigators say their success delivering it through the test animals’ noses may help them develop easier-to-use therapies for people with sleep-related breathing problems such as sleep apnea.

The findings were published online Oct. 12 in the American Journal of Respiratory and Critical Care Medicine.

Leptin, a hormone made by fat cells that was first identified in 1994, targets the brain’s appetite center, helping to regulate appetite. “Although leptin’s potential for treating obesity and curbing overeating failed to materialize in human trials, its role in the respiratory system has triggered new rounds of therapeutic possibilities,” says Vsevolod Polotsky, M.D., Ph.D., professor of pulmonary and critical care medicine at the Johns Hopkins University School of Medicine, and senior author of the study. His laboratory has been studying the hormone for more than 20 years.

A particular focus of his research is the search for new strategies to treat obstructive sleep apnea, a serious and even potentially lethal condition that affects approximately 30 percent of U.S. adults, Polotsky says. The prevalence increases to 50 percent among obese populations. The disorder is marked by frequent, brief periods when breathing stops during sleep due to upper airways closing. The result is oxygen deprivation. People with obesity are also at higher than usual risk of another sleep breathing problem called obesity hypoventilation syndrome, in which brain centers that regulate breathing during sleep operate abnormally and fail to increase breathing appropriately in response to carbon dioxide, which results in the buildup of carbon dioxide in the blood. The syndrome often accompanies sleep apnea.

Currently, the most common effective treatment for these sleep problems is regularly wearing a continuous positive airway pressure (CPAP) mask and machine, which mechanically increases air pressure in the throat to keep airways open during sleep. But because CPAP machines must be worn at all times during sleep and some patients find them cumbersome, uncomfortable, noisy and confining, substantial numbers of people cannot tolerate them and stop their use.

Polotsky says previous research has shown that leptin is essential in regulating breathing, and can successfully treat sleep-disordered breathing symptoms in obese mice lacking leptin. However, mice with diet-induced obesity are resistant to the leptin hormone and failed to respond when leptin was injected into the belly (or abdomen).

“One major reason for leptin-resistance is that it is hard for injected hormone to get through the blood-brain barrier and into the target brain cells,” says Slava Berger, a postdoctoral fellow in Polotsky’s lab and the first author of the paper. “We suspected that administering leptin through the nose might circumvent that barrier and overcome leptin-resistance in our test animals.”

To test that idea, the researchers first made adult male mice obese by feeding them a high-fat diet for 16 weeks. Since leptin can cause weight loss in the long term—which also reduces breathing problems —the researchers first assessed the immediate effect of a single dose of leptin (0.4 milligrams per kilogram of body weight) on sleep breathing before the weight-loss effect could take place. In both mice receiving leptin and those not receiving it?either squirted in the nose or injected in the belly?the researchers compared how much air mice inhaled, measured by changes in temperature, and the number of times mice experienced inadequate oxygen during sleep. They looked at blood oxygen levels by putting neck collars on mice, which were similar to the clips used on human fingers in urgent care settings to measure blood oxygen levels. The results indicated that only mice given leptin through the nose showed increased ventilation by over 40 percent during sleep, which alleviated upper airway obstruction and cut the number of times the mice had insufficient oxygen levels by more than half.

The researchers stained neurons from the brains of mice given leptin through the nose and found that the leptin receptor on the surface of the neurons had detected leptin, meaning this method of delivery bypassed the blood-brain barrier and transported leptin directly to the brain, thus avoiding leptin-resistance.

To further look at the longer term metabolic effects of leptin treatment, researchers treated a subset of their obese mice with leptin through the nose or the abdomen for two weeks. Again, only mice treated with leptin through the nose showed reduction in food intake and weight loss. Those mice lost 1 gram, almost 3 percent of total body weight, while the mice given leptin in the abdomen gained more than 3 grams, indicating leptin resistance.

“We believe our study provides the first evidence of its kind that giving leptin through the nose eases sleep disordered breathing,” says Polotsky. “In the future, we plan studies to look at the effects of different doses of leptin administered through the nose in mice.”

“Identifying key molecules that regulate breathing and how these molecules could be used to treat medical conditions such as sleep apnea is a significant achievement,” said Michael Twery, Ph.D., Director of the National Center on Sleep Disorders Research at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health. “The discovery sets the stage on which new treatment options can be developed.”

The researchers caution that, as was the case with leptin’s use to treat obesity, mouse studies may not be applicable to humans. “We believe that leptin treatment should be tested in humans at some point, but we first need to look into the potential side effects, allergic reactions and other factors before that can happen,” says Polotsky.

Costs, too, are a consideration for future therapies. According to the American Sleep Association, an average CPAP costs $500-$3,000. The current clinical use of leptin in the form of metreleptin—an extremely expensive synthetic replacement for leptin—treats rare cases of leptin deficiency at hundreds of thousands of dollars per year. However, Polotsky and Berger estimate that if nasal leptin is found safe and effective for clinical use, costs could be similar to inhaled forms of the hormone insulin, which runs about $25 per vial.


Explore further:
Leptin tied to sleep quality in obese patients with T2DM

Journal reference:
American Journal of Respiratory and Critical Care Medicine

Provided by:
Johns Hopkins University School of Medicine

Tagged with:

About author

Related Articles